Latest Isis Stories
CHICAGO, Jan. 27, 2015 /PRNewswire/ -- The struggle against ISIS is the latest in what seems like a never-ending war on terror that has cost trillions of dollars and thousands of lives.
CARLSBAD, Calif., Jan. 14, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
Isis-owned Subsidiary Launched to Conduct Development and Commercialization of Isis' Lipid Franchise Drugs CARLSBAD, Calif. and CAMBRIDGE, Mass., Jan.
Isis Strengthens Management Team Adding Strategic Business and Strategic Marketing Expertise CARLSBAD, Calif., Jan. 5, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
-- Collaboration Combines Isis' RNA-Targeted Technology With Expertise of Janssen in Autoimmune Disorders and Therapeutic Formulation -- CARLSBAD, Calif., Jan.
CARLSBAD, Calif., Jan. 2, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
ST. PETERSBURG, Fla., Dec.
ISIS-DMPK Rx Extends the Targeting of Antisense Drugs to Include Muscle Tissue CARLSBAD, Calif., Dec. 16, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
The brutality and psychopathic behavior of deranged fifteenth century warrior made comparable to ISIS mindset by Author at book event Palisades, NY (PRWEB)
Seven-fold lower incidence of VTE in patients treated with ISIS-FXI Rx compared with enoxaparin CARLSBAD, Calif., Dec. 7, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
- The parings of haberdine; also, any kind of fragments.